Detalhe da pesquisa
1.
Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7.
Lab Invest
; 104(4): 100321, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38154497
2.
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study.
Int J Cancer
; 155(1): 128-138, 2024 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447007
3.
Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference-a German expert perspective.
Strahlenther Onkol
; 200(6): 461-467, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38393398
4.
Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy (IRENE) in Locally Advanced or Metastatic Breast Cancer: Prospective Cohort Study.
Oncologist
; 28(12): e1152-e1159, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37555463
5.
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
N Engl J Med
; 380(7): 617-628, 2019 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30516102
6.
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.
Lancet Oncol
; 22(1): 85-97, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33357420
7.
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Lancet Oncol
; 22(8): 1151-1161, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34252375
8.
Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer.
Br J Cancer
; 125(1): 38-47, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33828257
9.
Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).
Breast Cancer Res Treat
; 185(1): 107-116, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32951084
10.
The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial.
J Med Internet Res
; 23(8): e29271, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34383675
11.
[Using Cervical Pessary to Prevent Premature Birth - a Clinical Analysis]. / Vermeidung der Frühgeburt durch Einlage eines Zerclage-Pessars Eine klinische retrospektive Kohortenanalyse.
Z Geburtshilfe Neonatol
; 225(1): 51-54, 2021 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-32392588
12.
Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883).
J Med Genet
; 56(9): 574-580, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30979843
13.
Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study Group.
Arch Gynecol Obstet
; 301(5): 1267-1274, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32277253
14.
Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto.
Breast Cancer Res
; 21(1): 60, 2019 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31077239
15.
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial.
Breast Cancer Res Treat
; 177(1): 103-114, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31134488
16.
Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials.
Ann Surg Oncol
; 26(12): 3892-3901, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350646
17.
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Lancet Oncol
; 19(1): 40-50, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29233559
18.
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial.
Lancet
; 389(10075): 1195-1205, 2017 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28215665
19.
Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials.
Breast Cancer Res Treat
; 167(1): 59-71, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28875243
20.
Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a subanalysis of the ALTTO trial (BIG 206; NCCTG (Alliance) N063D).
Breast Cancer Res Treat
; 191(1): 225, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625860